Where does T-Knife Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across T-Knife Therapeutics's 1 recorded funding rounds.

Premier Alternatives

T-Knife Therapeutics

Biotechnology

T-Knife Therapeutics is a private biotechnology company. It has raised $110 million across 1 recorded round; the latest was an $110 million Series B in Aug 2021.

PMV mark · valuation

—

Oct 2026

Priced at

—

Total raised

$110.0M

Last round

Later Stage VC (Series B)

Aug 2021

Cap table — not yet on record

T-Knife Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Pro

The prices on T-Knife Therapeutics

·18 fund marks: filer, period, implied $/share

Pro · $99 a month

List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Frequently asked about T-Knife Therapeutics

Where does T-Knife Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across T-Knife Therapeutics's 1 recorded funding rounds.